companydata.dkRenescience A/S: Financial statements 2018
CVR: 31846803
Renescience A/S (CVR 31846803) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -24,267,000 and a net result of DKK -19,092,000 compared with DKK -7,760,000 the year before. Equity amounted to DKK 62,694,000. The solvency ratio was 88.1%.
- Gross Profit
- -24,267,000 kr.
- Profit/Loss
- -19,092,000 kr.
- Equity
- 62,694,000 kr.
- Total Assets
- 71,186,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -24.3 mio. | -19.1 mio. | 62.7 mio. | - |
| 2017 | - | -9.7 mio. | -7.8 mio. | 81.8 mio. | - |
| 2016 | - | -37.1 mio. | -29.5 mio. | 89.5 mio. | - |
| 2015 | - | -56 mio. | -43.2 mio. | 24.1 mio. | - |
| 2014 | - | -26.4 mio. | -19.4 mio. | 33.3 mio. | - |
Keep an eye on Renescience A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
Renescience A/S has published its annual report for 2017. Gross profit came to DKK -9,657,000, and the net result was DKK -7,760,000.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Holm Lerke-Møller. The company is owned by Ørsted New Bio Solutions Holding A/S. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity amounted to DKK 73,470,000.